SI-BONE, Inc. Chief Executive Officer Laura Francis filed a Form 4 on November 6, 2026, disclosing the sale of 75,000 shares of common stock on November 4, 2026, pursuant to a Rule 10b5-1 trading plan.

Key Highlights

  • Reporting person: Laura Francis, Director and Chief Executive Officer of SI-BONE, Inc. (NASDAQ:SIBN)
  • Shares sold: 75,000 shares of common stock disposed of on November 4, 2026, with a weighted average sale price of $25.3019
  • Price range: Individual trades were executed at prices ranging from $25.00 to $25.90 per share, according to the filing
  • 10b5-1 plan: The sale was made pursuant to a Rule 10b5-1 trading plan dated June 13, 2025
  • Indirect holdings after transaction: 304,256 shares held indirectly by The David & Laura Joint Rev Tr
  • Direct holdings after transaction: 368,129 shares held directly, including 355,697 shares issuable on settlement of restricted stock units

SI-BONE CEO Laura Francis Disposes of 75,000 Shares Under Pre-Established Trading Plan

According to the Form 4 filed with the U.S. Securities and Exchange Commission on November 6, 2026, Laura Francis, who serves as both Director and Chief Executive Officer of SI-BONE, Inc. (NASDAQ:SIBN), reported the sale of 75,000 shares of common stock on November 4, 2026. The filing indicates the transaction was effected pursuant to a Rule 10b5-1 trading plan that was established on June 13, 2025. The sale carried a transaction code of "S," indicating a market sale.

The filing discloses that the 75,000 shares were disposed of at a weighted average price of $25.3019 per share, with individual trades executed across a range of $25.00 to $25.90. The filing states that Francis "undertakes to provide Issuer, any security holder of the Issuer, or the Staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range." The shares sold were held indirectly through The David & Laura Joint Rev Tr prior to the transaction.

Following the reported transaction, the filing shows Francis holds 304,256 shares indirectly through The David & Laura Joint Rev Tr, and 368,129 shares directly. The direct figure includes 355,697 shares described as "issuable on settlement of restricted stock units granted to the Reporting Person," with each unit representing "a contingent right to receive one share of the Issuer's common stock." The Form 4 was signed by Michael A. Pisetsky as Attorney-in-Fact for Laura A. Francis on November 6, 2026.

What Was Disclosed

SI-BONE CEO Laura Francis reported a sale of 75,000 common shares on November 4, 2026, at a weighted average of $25.3019, under a pre-established 10b5-1 plan. After the transaction, she holds 304,256 shares indirectly and 368,129 shares directly.